Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Non Operating Investment Income (2013 - 2021)

Updated

Ernexa Therapeutics' Non Operating Investment Income came in at -$9.65 million for FY2021.

Analysis

Ernexa Therapeutics (ERNA) Non Operating Investment Income (2013 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Ernexa Therapeutics 3.46 Mn 3.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -50,000.00
Mar 31, 2021 -9.60 Mn
Sep 30, 2013 115,000.00
API Access

Ernexa Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ERNA&period=max&api_key=YOUR_API_KEY